DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Buller HR, Lensing AWA, Prins MH. , et al; Einstein-DVT Dose-Ranging Study investigators.
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
Blood 2008;
112 (06) 2242-2247
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.